The mechanism of non-steroidal anti-inflammatory drugs on osteoclast differentiation and activation.
Project/Area Number |
22791800
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Functional basic dentistry
|
Research Institution | Showa University |
Principal Investigator |
|
Project Period (FY) |
2010 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 歯科薬理学 / 破骨細胞 / NSAIDs / COX / 歯学 / osteoclast / cyclooxygenase |
Research Abstract |
Non-steroidal anti-inflammatory drugs(NSAIDs) have regulatory effect on bone remodeling. The efficacy of NSAIDs on bone remodeling is controversial. In clinics, NSAIDs progress bone repair as their inhibitory effect of inflammatory factors ; in contrast, NSAIDs delay bone fracture healing in animal models. The aim of this study was to elucidate the mechanism of NSAIDs on osteoclast differentiation and bone resorptive activity. Cyclloxygenase(COX)-1 and-2 transcripts were appeared in early stage of osteoclast differentiation(day3). COX-2 increased on mature osteoclasts and lipopolysaccharide stimulated inflammatory mature osteoclasts. Level of COX-2 transcript has efficacy on extracellular signal-regulated kinase appearance. These results showed that COX-1 and-2 involved in osteoclasts have regulatory effect on osteoclasts differentiation and bone resorptive activity.
|
Report
(3 results)
Research Products
(14 results)
-
-
-
-
-
-
-
[Presentation] Pam3CSK4, a TLR2 Agonist, Induces in vitro Osteoclastogenesis RANKL Independently and Resorbs Alveolar Bone in Rats2011
Author(s)
Yano A, Suzuki K, Morohashi T, Arimoto T, Karakawa A, Sakai N, Igarashi T, Yamamoto M, Yamada S
Organizer
第31回昭和歯学会総会
Place of Presentation
昭和大学
Year and Date
2011-07-02
Related Report
-
[Presentation] Pam3CSK4, a TLR2 agonist, induces in vitro osteoclastogenesis RANKL-independently and resorbs alveolar bone in rats2011
Author(s)
Yano A, Suzuki K, Morohashi T, Arimoto T, Karakawa A, Igarashi T, Shinoda H, Yamamoto M, Yamada S
Organizer
ASBMR 2011 Annual Meeting
Place of Presentation
アメリカ合衆国
Related Report
-
[Presentation] Pam3CSK4, a TLR2 agonist, induces in vitro osteoclastogenesis RANKL-independently and resorbs alveolar bone in rats2011
Author(s)
Akiko Yano, Keiko Suzuki, Tomio Morohashi, Takafumi Arimoto, Akiko Karakawa, Takeshi Igarashi, Hisashi Shinoda, Matsuo Yamamoto, Shoji Yamada
Organizer
ASBMR 2011 Annual Meeting
Place of Presentation
アメリカ
Related Report
-
-
-
-
-